NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

被引：0

作者：

Nayak, Lakshmi ^{[1
]}

Molinaro, Annette ^{[2
]}

Peters, Katherine ^{[3
]}

Clarke, Jennifer ^{[2
]}

Jordan, Justin ^{[4
]}

de Groot, John ^{[5
]}

Nghiemphu, Phioanh ^{[6
]}

Kaley, Thomas ^{[7
]}

Colman, Howard ^{[8
]}

McCluskey, Christine ^{[1
]}

Gaffey, Sarah ^{[1
]}

Smith, Timothy ^{[9
]}

Cote, David ^{[10
]}

Severgnini, Mariano ^{[1
]}

Yearley, Jennifer ^{[11
]}

Zhao, Qing ^{[11
]}

Blumenschein, Wendy ^{[11
]}

Duda, Gabriel ^{[4
]}

Muzikansky, Alona ^{[4
]}

Jain, Rakesh ^{[12
]}

Wen, Patrick ^{[1
]}

Reardon, David ^{[13
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA

[3] Duke Univ, Med Ctr, Durham, NC USA

[4] Massachusetts Gen Hosp, Boston, MA 02114 USA

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[6] Univ Calif Los Angeles, Los Angeles, CA USA

[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[8] Huntsman Canc Inst, Salt Lake City, UT USA

[9] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA

[10] BWH, Boston, MA USA

[11] Merck, Kenilworth, NJ USA

[12] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Labs, Boston, MA 02115 USA

[13] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA

来源：

NEURO-ONCOLOGY | 2020年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NCOG-44

引用

页码：138 / 139

页数：3

共 50 条

[1] Neurologic assessment in neuro-oncology (NANO) scale in a prospective phase II trial of anti-PD1 antibody, pembrolizumab with or without bevacizumab in patients with recurrent glioblastoma.
Nayak, Lakshmi
Smith, Timothy
Gaffey, Sarah C.
Peters, Katherine B.
Clarke, Jennifer Leigh
Jordan, Justin T.
De Groot, John Frederick
Nghiemphu, Phioanh Leia
Kaley, Thomas Joseph
Colman, Howard
Armstrong, Terri
Taphoorn, Martin J.
Caruso, Victoria
Debruyne, Myriam Bednarek
Bhavsar, Chinmay
Molinaro, Annette M.
Severgnini, Mariano
Wen, Patrick Y.
Reardon, David A.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[2] PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS
Reardon, David
Molinaro, Annette
Peters, Katherine
Clarke, Jennifer
Jordan, Justin
de Groot, John
Nghiemphu, Phioanh
Kaley, Thomas
Colman, Howard
McCluskey, Christine
Smith, Timothy
Cote, David
Severgnini, Mariano
Yearley, Jennifer
Zhao, Qing
Blumenschein, Wendy
Duda, Gabriel
Muzikansky, Alona
Jain, Rakesh
Wen, Patrick
Nayak, Lakshmi
NEURO-ONCOLOGY, 2020, 22 : 40 - 40
[3] Phase II study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma (rGBM) patients
Reardon, David A.
Nayak, Lakshmi
Peters, Katherine B.
Clarke, Jennifer Leigh
Jordan, Justin T.
De Groot, John Frederick
Nghiemphu, Phioanh Leia
Kaley, Thomas Joseph
Colman, Howard
Gaffey, Sarah C.
Caruso, Victoria
Debruyne, Myriam Bednarek
Bhavsar, Chinmay
Molinaro, Annette M.
Smith, Timothy
Severgnini, Mariano
Wen, Patrick Y.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[4] Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Nayak, Lakshmi
Molinaro, Annette M.
Peters, Katherine
Clarke, Jennifer L.
Jordan, Justin T.
de Groot, John
Nghiemphu, Leia
Kaley, Thomas
Colman, Howard
McCluskey, Christine
Gaffey, Sarah
Smith, Timothy R.
Cote, David J.
Severgnini, Mariano
Yearley, Jennifer H.
Zhao, Qing
Blumenschein, Wendy M.
Duda, Dan G.
Muzikansky, Alona
Jain, Rakesh K.
Wen, Patrick Y.
Reardon, David A.
CLINICAL CANCER RESEARCH, 2021, 27 (04) : 1048 - 1057
[5] The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary Glioblastoma
Ung, Timothy H.
Ney, Douglas E.
Damek, Denise
Rusthoven, Chad G.
Youssef, A. Samy
Lillehei, Kevin O.
Ormond, D. Ryan
NEUROSURGERY, 2019, 84 (03) : 687 - 695
[6] Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
Soffietti, Riccardo
Trevisan, Elisa
Bertero, Luca
Cassoni, Paola
Morra, Isabella
Fabrini, Maria Grazia
Pasqualetti, Francesco
Lolli, Ivan
Castiglione, Anna
Ciccone, Giovannino
Ruda, Roberta
JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (03) : 533 - 541
[7] Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
Riccardo Soffietti
Elisa Trevisan
Luca Bertero
Paola Cassoni
Isabella Morra
Maria Grazia Fabrini
Francesco Pasqualetti
Ivan Lolli
Anna Castiglione
Giovannino Ciccone
Roberta Rudà
Journal of Neuro-Oncology, 2014, 116 : 533 - 541
[8] Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma
Iwamoto, Fabio M.
Tanguturi, Shyam K.
Nayak, Lakshmi
Wang, Tony J.
Desai, Arati
Lustig, Robert A.
Bagley, Stephen
Wong, Eric T.
Hertan, Lauren M.
Mccluskey, Christine
Hayden, Julia
Muzikansky, Alona
Nakhawa, Shreya
Japo, Julia
Bossi, Connor C.
Meylan, Maxime
Tian, Ye
Barlow, Graham L.
Speliakos, Paul
Ayoub, Georges
Meredith, David M.
Ligon, Keith L.
Haas-Kogan, Daphne
Huang, Kun
Wucherpfennig, Kai W.
Wen, Patrick Y.
Reardon, David A.
CLINICAL CANCER RESEARCH, 2025, 31 (02) : 316 - 327
[9] THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE: A TOOL TO ASSESS NEUROLOGIC FUNCTION FOR INTEGRATION IN THE RADIOLOGIC ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA
Reardon, D. A.
Nayak, L.
DeAngelis, L. M.
Wen, P. Y.
Brandes, A. A.
Soffietti, R.
Peerboom, D. M.
Lin, N. U.
Chamberlain, M.
Macdonald, D.
NEURO-ONCOLOGY, 2014, 16
[10] THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE: A TOOL TO ASSESS NEUROLOGIC FUNCTION FOR INTEGRATION IN THE RADIOLOGIC ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA
Nayak, Lakshmi
DeAngelis, Lisa M.
Wen, Patrick Y.
Brandes, Alba A.
Soffietti, Riccardo
Peereboom, David M.
Lin, Nancy U.
Chamberlain, Marc
Macdonald, David
Galanis, Evanthia
Perry, James
Jaeckle, Kurt
Mehta, Minesh
Stupp, Roger
van den Bent, Martin
Reardon, David A.
NEURO-ONCOLOGY, 2013, 15 : 123 - 123

← 1 2 3 4 5 →